Insider Transactions in Q2 2023 at Ptc Therapeutics, Inc. (PTCT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2023
|
Michael Schmertzler |
SELL
Open market or private sale
|
Direct |
1,000
-0.85%
|
$44,000
$44.86 P/Share
|
|
Jun 06
2023
|
William F. Bell Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+38.46%
|
-
|
|
May 23
2023
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
2,652
-10.54%
|
$156,468
$59.53 P/Share
|
|
May 23
2023
|
Emma Reeve |
BUY
Exercise of conversion of derivative security
|
Direct |
2,652
+9.25%
|
$87,516
$33.43 P/Share
|
|
May 22
2023
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
7,116
-22.38%
|
$419,844
$59.53 P/Share
|
|
May 22
2023
|
Emma Reeve |
BUY
Exercise of conversion of derivative security
|
Direct |
7,116
+17.05%
|
$234,828
$33.43 P/Share
|
|
May 22
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,013
-2.03%
|
$118,767
$59.32 P/Share
|
|
May 19
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,403
-11.44%
|
$371,374
$58.96 P/Share
|
|
May 18
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
788
-1.39%
|
$45,704
$58.71 P/Share
|
|
May 17
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
8,048
-6.28%
|
$466,784
$58.51 P/Share
|
|
May 11
2023
|
Allan Steven Jacobson |
SELL
Open market or private sale
|
Direct |
23,000
-26.53%
|
$1,288,000
$56.04 P/Share
|
|
May 11
2023
|
Allan Steven Jacobson |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+39.42%
|
$230,000
$10.85 P/Share
|
|
Apr 21
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,692
-3.72%
|
$258,060
$55.26 P/Share
|
|
Apr 21
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,692
+5.1%
|
$154,836
$33.02 P/Share
|
|
Apr 21
2023
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
4,328
-19.02%
|
$238,040
$55.31 P/Share
|
|
Apr 18
2023
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,211
-1.17%
|
$62,972
$52.04 P/Share
|
|
Apr 18
2023
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+20.02%
|
-
|
|
Apr 18
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
732
-1.12%
|
$38,064
$52.04 P/Share
|
|
Apr 17
2023
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
11,429
-30.76%
|
$582,879
$51.06 P/Share
|
|
Apr 17
2023
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
11,429
+34.26%
|
$205,722
$18.01 P/Share
|
|
Apr 17
2023
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
61,923
-23.97%
|
$3,158,073
$51.42 P/Share
|
|
Apr 17
2023
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
61,923
+17.23%
|
$1,857,690
$30.86 P/Share
|